InMode Says Haifa District Court Denied Steel Partners Affiliate's Request For Temporary Injunctive Relief In Its Entirety, Awarded Company Certain Costs
https://www.sec.gov/Archives/edgar/data/1742692/000117891326004040/zk2635934.htm
Stocks · News reference
InMode Reports Preliminary Q2 Sales Of $95.2M-$95.4M; Reaffirms FY2026 Sales Guidance Of $365M-$375M
InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the second quarter of 2026 before the Nasdaq market opens on
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
InMode Lowers FY2026 Adj EPS Guidance from $1.33-$1.38 to $1.29-$1.34 vs $1.34 Est; Affirms FY2026 Sales Guidance of $365.000M-$375.000M vs $370.301M Est
InMode (NASDAQ:INMD) lowers FY2026 Adj EPS guidance from $1.33-$1.38 to $1.29-$1.34 vs $1.34 analyst estimate. Affirms FY2026 sales outlook from $365.000 million-$375.000 million to $365.000 million-$375.000 million vs
InMode Q2 Adj. EPS $0.35 Beats $0.33 Estimate, Sales $95.589M Beat $93.032M Estimate
InMode (NASDAQ:INMD) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.33 by 6.06 percent. This is a 25.53 percent decrease over earnings of $0.47 per share from the same
INmune Bio Receives ~$4.2M Development Cash Rebate From Australia